XLXinjian Li

Xinjian Li

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Xinjian Li has a total of 11 co-authors. Here are the top co-authors by number of shared publications:

  • Dong Wang

    Department of Nephrology, Affiliated Hospital of Jining Medical University, Jining, Shandong, China

    1 shared publication
  • Gongshe Yang

    Laboratory of Animal Fat Deposition and Muscle Development, College of Animal Science and Technology, Northwest A&F University, Yangling 712100, China

    1 shared publication
  • Guoxi Li

    Henan Agricultural University

    1 shared publication
  • Kun Zhang

    Department of Nephrology, Affiliated Hospital of Jining Medical University, Jining, Shandong, China

    1 shared publication
  • Mingmin Wei

    Department of Nephrology, Affiliated Hospital of Jining Medical University, Jining, Shandong, China

    1 shared publication
  • Nan Zhang

    Department of Nephrology, Affiliated Hospital of Jining Medical University, Jining, Shandong, China

    1 shared publication

Latest Publications

  • Open Access

    Astragalus polysaccharides protect renal function and affect the TGF-β/Smad signaling pathway in streptozotocin-induced diabetic rats

    by Xue Meng, Mingmin Wei, Dong Wang, Xiaohan Qu, Kun Zhang, Nan Zhang, Xinjian Li

    The objective was to observe the effects of Astragalus polysaccharides on diabetes and on regulation of the TGF-β/Smad signaling pathway. A type 2 diabetic rat model was established with a high-fat diet in combination with low-dose streptozotocin (35 mg/kg). Astragalus polysaccharides were applied as treatment intervention and changes in blood glucose and kidney morphology and function were assessed. Eight weeks after model establishment, kidney weight as a proportion of total weight (KW/TW) in the high-, medium-, and low-dose Astragalus polysaccharide groups was significantly lower than that in the model group, and the KW/TW value gradually decreased with increasing dose of polysaccharides in each treatment group. Fasting blood glucose in the low- and medium-dose Astragalus polysaccharide groups was numerically lower than that in the model group and fasting blood glucose in rats in the high-dose group was significantly lower than that in the model group. Levels of 24-hour urinary microalbumin, creatinine, blood urea nitrogen, collagens I, III, and IV, α-smooth muscle actin, transforming growth factor-β1, and Smad3 in Astragalus polysaccharide groups (all doses) were significantly lower than those in the model group. Astragalus polysaccharide significantly improved blood glucose and protected kidney function in a rat diabetes model.


  • Biological role of MicroRNA-103 based on expression profile and target genes analysis in pigs

    by Guoxi Li, Zongsong Wu, Xinjian Li, Xiaomin Ning, Yanjie Li, Gongshe Yang

    MicroRNAs (miRNAs) are endogenously expressed RNAs consisting of 20–24 nucleotides. These molecules are thought to repress protein translation by binding to target mRNAs. However, biological functions have not been assigned to most of the 175 porcine miRNAs registered in miRBase (release 15.0). In an effort to uncover miR-103 important in pigs, we examined the integrative tissue expression profile and gene ontology (GO) term enrichment of predicted target genes to determine the global biological functions of miR-103. Our results demonstrated that miR-103 is involved in various biological processes including brain development, lipid metabolism, adipocyte differentiation, hematopoiesis, and immunity. Moreover, we also experimentally verified effects of miR-103 in porcine preadipocytes. miR-103 levels increased in differentiating adipocytes, and inhibition of miR-103 effectively inhibited preadipocyte differentiation. In addition, mRNA levels of the putative miR-103 target RAI14 were higher in miR-103 inhibitor-treated adipocytes. These results demonstrate that miR-103 is involved in porcine preadipocyte differentiation and may act through the putative target gene RAI14. In a word, our data provide new insights into the global biological role of miR-103.